Literature DB >> 16607158

Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.

Elena Dubcenco1, Clifford A Ottaway, Dean L Chen, Jeffrey P Baker.   

Abstract

Anti-TNFalpha drugs are currently used in the treatment of patients with Crohn's disease. Studies have reported neurological side effects occurring after anti-TNFalpha treatment, including infliximab-induced complications.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16607158     DOI： 10.1097/00042737-200605000-00021

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


  7 in total

1.  Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

Authors:  K M De Felice; M Novotna; F T Enders; W A Faubion; W J Tremaine; O H Kantarci; L E Raffals
Journal:  Aliment Pharmacol Ther       Date:  2014-10-27       Impact factor: 8.171

Review 2.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 3.  Neurological adverse events associated with anti-tumor necrosis factor α treatment.

Authors:  Antonio G Tristano
Journal:  J Neurol       Date:  2010-05-22       Impact factor: 4.849

Review 4.  CNS Demyelination with TNF-α Blockers.

Authors:  Elissavet Kemanetzoglou; Elisabeth Andreadou
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

5.  Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Authors:  E Andreadou; E Kemanetzoglou; Ch Brokalaki; M E Evangelopoulos; C Kilidireas; A Rombos; E Stamboulis
Journal:  Case Rep Neurol Med       Date:  2013-05-16

6.  Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Authors:  Evripidis Kaltsonoudis; Anastasia K Zikou; Paraskevi V Voulgari; Spyridon Konitsiotis; Maria I Argyropoulou; Alexandros A Drosos
Journal:  Arthritis Res Ther       Date:  2014-06-17       Impact factor: 5.156

7.  Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists.

Authors:  Claudia Bruè; Cesare Mariotti; Ilaria Rossiello; Andrea Saitta; Alfonso Giovannini
Journal:  Case Rep Ophthalmol       Date:  2016-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.